The phase 2 clinical trial of Ocular Therapeutix’s drug-eluting insert didn’t end in tears, but in this case, that translated to the opposite of success for the proposed treatment for dry eye disease.

Please provide your email address to receive an email when new articles are posted on . Eyes with the insert had significantly less corneal and conjunctival staining at week 4, the latter of which ...